BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 110966
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.110966
Table 6 Examples of ongoing trials in autoimmune hepatitis
Ref.

Treatment
Mechanism of action
Stage of development
Mack et al[2], 2020; Whitehead and Kriegermeier[42], 2020; Reau et al[48], 20241ZetomipzomibImmunoproteasome inhibitorPhase 2
2Ianalumab, BelimumabAntibody-dependent cellular cytotoxicity mediated B-cell depletion through B-cell activating factor inhibitionPhase 2/3
3JKB-122Toll-like receptor-4 inhibition Phase 2
4Mesenchymal stromal cellsInduction of regulatory T-cell differentiation and suppression of lymphocyte activationPhase 1/2
5Synthetic preimplantation factor (s-PIF)Creation of immunosuppressive and immunomodulatory environment of pregnancyPhase 1


Write to the Help Desk